A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi-Reference-Cited by-同舟云学术

A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi

Published:2015-02 Issue:6 Volume:33 Page:783-788
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kothari Neha,Kothari Sudeep,Choi Young Joo,Dey Ayan,Briles David E.,Rhee Dong Kwon,Carbis Rodney

Funder

Swedish International Development Cooperation

Korean National Research Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. Burden of disease caused by Streptococcous pneumoniae in children younger than 5 years: global estimates;O’Brien;Lancet,2009

2. The global burden of typhoid fever;Crump;Bull World Health Organ,2004

3. Physico-chemical properties of Salmonella Typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity;An;Vaccine,2011

4. Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein;Kothari;Vaccine,2014

5. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease;Baril;Vaccine,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach;Frontiers in Cellular and Infection Microbiology;2023-11-15

2. Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D;Frontiers in Immunology;2023-08-23

3. Prevalence and Homology of the Pneumococcal Serine-Rich Repeat Protein at the Global Scale;Microbiology Spectrum;2023-06-15

4. Pneumococcal Surface Protein A: A Promising Candidate for the Next Generation of Pneumococcal Vaccines;Cellular and Molecular Biology;2022-01-02

5. Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development;BMC Research Notes;2020-06-15